Long intergenic non-protein coding RNA 1034 (LINC01034)

Long intergenic non-protein coding RNA 1034 (LINC01034, also known as TCONS_00021570) is a long intergenic non-protein coding RNA, classified as a lincRNA, meaning it is a long non-coding RNA transcript longer than 200 nucleotides that does not overlap with protein-coding regions[1][2][5]. LincRNAs play diverse regulatory roles in gene expression, frequently acting at the transcriptional or epigenetic level, usually with subtle effects and often in a tissue- or context-specific manner[4][5][6]. LINC01034 has not been specifically described as a disease driver or as a therapeutic target. There are no drugs, mechanisms of action, or well-established biomarker or safety concerns associated specifically with LINC01034 at this time[1][2]. LINC01034 is a member of the lincRNA family, a group of non-coding RNA molecules that regulate gene expression in various ways, such as chromatin remodeling, transcriptional interference, or as molecular scaffolds or decoys[4][5][6]. While many lincRNAs—including other members like LINC01857—have prominent roles in cancer and other diseases, there is currently no experimental evidence for a well-defined role of LINC01034 in specific pathways or diseases[1][2]. No evidence suggests that LINC01034 encodes a protein or functions as a receptor, enzyme, transporter, transcription factor, or directly as a therapeutic target[1][2][5][6].

Other names

TCONS_00021570